Publikationen in Zusammenarbeit mit Forschern von Universitat d'Alacant (10)

2023

  1. Rationale for combined therapies in severe-to-critical COVID-19 patients

    Frontiers in Immunology, Vol. 14

2022

  1. Cardiac protection induced by urocortin-2 enables the regulation of apoptosis and fibrosis after ischemia and reperfusion involving miR-29a modulation

    Molecular Therapy - Nucleic Acids, Vol. 27, pp. 838-853

  2. Considerations for Clinical Use of Mesenchymal Stromal Cells

    Handbook of Stem Cell Therapy: Volume 1 (Springer Nature), pp. 51-102

  3. Mesenchymal Stromal Cells for COVID-19 Critical Care Patients: A Present Hope

    Handbook of Stem Cell Therapy: Volume 1 (Springer Nature), pp. 163-191

  4. Pdx1 Is Transcriptionally Regulated by EGR-1 during Nitric Oxide-Induced Endoderm Differentiation of Mouse Embryonic Stem Cells

    International Journal of Molecular Sciences, Vol. 23, Núm. 7

2021

  1. A new shortened protocol to obtain islet-like cells from hESC-derived ductal cells

    In Vitro Cellular and Developmental Biology - Animal, Vol. 57, Núm. 6, pp. 587-597

  2. Editorial: A Compendium of Recent Research on Stem Cell-Based Therapy for Covid-19

    Frontiers in Cell and Developmental Biology

  3. Efficacy and safety of intramuscular administration of allogeneic adipose tissue derived and expanded mesenchymal stromal cells in diabetic patients with critical limb ischemia with no possibility of revascularization: study protocol for a randomized controlled double-blind phase II clinical trial (The NOMA Trial)

    Trials, Vol. 22, Núm. 1

2019

  1. Oestrogen receptor β mediates the actions of bisphenol-A on ion channel expression in mouse pancreatic beta cells

    Diabetologia, Vol. 62, Núm. 9, pp. 1667-1680

1999

  1. Phenylarsine oxide increases intracellular calcium mobility and inhibits Ca2+-dependent ATPase activity in thymocytes

    Molecular Genetics and Metabolism, Vol. 68, Núm. 3, pp. 363-370